ANNX
Price
$2.42
Change
+$0.12 (+5.22%)
Updated
Jun 4, 04:10 PM (EDT)
Capitalization
252.34M
75 days until earnings call
IDYA
Price
$21.19
Change
-$0.45 (-2.08%)
Updated
Jun 4, 04:24 PM (EDT)
Capitalization
1.9B
69 days until earnings call
Interact to see
Advertisement

ANNX vs IDYA

Header iconANNX vs IDYA Comparison
Open Charts ANNX vs IDYABanner chart's image
Annexon
Price$2.42
Change+$0.12 (+5.22%)
Volume$818
Capitalization252.34M
IDEAYA Biosciences
Price$21.19
Change-$0.45 (-2.08%)
Volume$27.79K
Capitalization1.9B
ANNX vs IDYA Comparison Chart
Loading...
ANNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANNX vs. IDYA commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANNX is a StrongBuy and IDYA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (ANNX: $2.30 vs. IDYA: $21.64)
Brand notoriety: ANNX and IDYA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANNX: 67% vs. IDYA: 98%
Market capitalization -- ANNX: $252.34M vs. IDYA: $1.9B
ANNX [@Biotechnology] is valued at $252.34M. IDYA’s [@Biotechnology] market capitalization is $1.9B. The market cap for tickers in the [@Biotechnology] industry ranges from $321.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANNX’s FA Score shows that 1 FA rating(s) are green whileIDYA’s FA Score has 0 green FA rating(s).

  • ANNX’s FA Score: 1 green, 4 red.
  • IDYA’s FA Score: 0 green, 5 red.
According to our system of comparison, IDYA is a better buy in the long-term than ANNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANNX’s TA Score shows that 5 TA indicator(s) are bullish while IDYA’s TA Score has 6 bullish TA indicator(s).

  • ANNX’s TA Score: 5 bullish, 3 bearish.
  • IDYA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both ANNX and IDYA are a good buy in the short-term.

Price Growth

ANNX (@Biotechnology) experienced а +16.75% price change this week, while IDYA (@Biotechnology) price change was +11.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.19%. For the same industry, the average monthly price growth was +4.99%, and the average quarterly price growth was -2.11%.

Reported Earning Dates

ANNX is expected to report earnings on Aug 18, 2025.

IDYA is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+6.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($1.9B) has a higher market cap than ANNX($252M). IDYA YTD gains are higher at: -15.798 vs. ANNX (-55.166). ANNX has higher annual earnings (EBITDA): -151.48M vs. IDYA (-356.46M). IDYA has more cash in the bank: 693M vs. ANNX (312M). IDYA has less debt than ANNX: IDYA (26M) vs ANNX (29M). IDYA has higher revenues than ANNX: IDYA (7M) vs ANNX (0).
ANNXIDYAANNX / IDYA
Capitalization252M1.9B13%
EBITDA-151.48M-356.46M42%
Gain YTD-55.166-15.798349%
P/E RatioN/AN/A-
Revenue07M-
Total Cash312M693M45%
Total Debt29M26M112%
FUNDAMENTALS RATINGS
IDYA: Fundamental Ratings
IDYA
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
62
SMR RATING
1..100
45
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANNXIDYA
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
60%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
70%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
76%
Declines
ODDS (%)
Bearish Trend 30 days ago
90%
Bearish Trend 14 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
77%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
ANNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MCSSX39.910.23
+0.58%
NYLI WMC Enduring Capital Investor Class
RYLCX72.55N/A
N/A
Rydex Leisure C
DCINX17.74N/A
N/A
Dunham International Stock C
GLCTX29.60N/A
N/A
Goldman Sachs Large Cap Gr Insghts Inv
OPTFX83.44N/A
N/A
Invesco Discovery Large Cap A

ANNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANNX has been loosely correlated with CCCC. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ANNX jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANNX
1D Price
Change %
ANNX100%
+8.49%
CCCC - ANNX
43%
Loosely correlated
+11.28%
IDYA - ANNX
43%
Loosely correlated
+1.98%
AURA - ANNX
42%
Loosely correlated
+2.76%
CRNX - ANNX
42%
Loosely correlated
+0.69%
TRML - ANNX
42%
Loosely correlated
+7.77%
More

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with CGON. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
+1.98%
CGON - IDYA
60%
Loosely correlated
+0.75%
IMNM - IDYA
59%
Loosely correlated
+2.21%
CRNX - IDYA
56%
Loosely correlated
+0.69%
ETNB - IDYA
55%
Loosely correlated
+0.59%
KRYS - IDYA
55%
Loosely correlated
+4.43%
More